HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
Rásarupplýsingar
HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast
This podcast is produced by pharmacy faculty to supplement study material and provide relevant drug and professional topics. We're hoping that our real-life clinical pearls and discussions will help you stay up-to-date and improve your pharmacy knowledge.
Nýlegir þættir
207 þættir
193 - Elevate Your Guideline Knowledge, Not Your BP: The New 2025 Hypertension Guidelines
In this episode, we review the newly published 2025 ACC/AHA hypertension guidelines.
Key Concepts
References
192 - Opioids Optional: Journavx, the New Acute Pain Management Alternative
In this episode, we discuss the evidence, safety, and place in therapy of Journavx® (suzetrigine), a newly approved analgesic with a unique non-opioid...
191 - The Ultimate Guide to ARBs: An In-depth Drug Class Review
In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of angiotensin receptor blocker...
190 - Can’t Stop, Won’t Drop … The BP That Just Won’t Quit: Diagnosis and Treatment of Resistant Hypertension
In this episode, we discuss the diagnosis and treatment of resistant hypertension, including a newer endothelin receptor antagonist (ERA) called aproc...
189 - Mice, Macrophages, and Metabolism: Browning Keeps Obesity at Bay
In this episode, we discuss the very early stages of drug targets and drug development with Dr. Mohd Shahid, PhD. Dr. Shahid’s research involves the I...
188 - The Clot Thickens: Key Updates from the 2025 Acute Coronary Syndromes Guidelines
In this episode, we review the new 2025 ACC/AHA Acute Coronary Syndrome (ACS) guidelines, with a particular focus on guideline recommendations for ana...
187 - Infectious Ambitions: A Pharmacist's Career Pivot from Clinical to Industry
In this episode, we interview Morgan Anderson, PharmD, BCIDP, a graduate of the RFUMS College of Pharmacy, about her career path from a pharmacy resid...
186 - Breaking the Bank or Breaking the Scale: Controversies Surrounding Compounded GLP-1s RAs for Weight Loss
In this episode, we discuss the efficacy and safety of semaglutide and tirzepatide for weight loss with a particular focus on the legal, regulatory, a...
185 - They Are Late, but Don’t Stress: The New 2024 Stress Ulcer Prophylaxis Guidelines
In this episode, we review the recommendations from the 2024 SCCM/ASHP stress ulcer prophylaxis guidelines and highlight three of the more recent land...
184 - Drop it Like it’s Hot! Deprescribing Pharmacotherapy When Appropriate
In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibitors, meman...
183 - The Ultimate Guide to Loop Diuretics: An In-Depth Drug Class Review
In this episode, we review the pharmacology, pharmacokinetics, adverse effects, monitoring, medicinal chemistry, and more of loop diuretics.
Key...
182 - 2023 Beers Criteria Update: Navigating Medications Safely in Older Patients
In this episode, we discuss principles for medication use in the geriatric patient population and summarize the updated 2023 American Geriatrics Socie...
181 - From Meds to Machine Learning: How AI is (and will) Revolutionizing Pharmacy Practice
In this episode, we discuss artificial intelligence large language models (LLMs) and how these will impact the future of the practice of pharmacy.
180 - The Ultimate Guide to Statins: An In-Depth Drug Class Review
In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of HMG CoA reductase inhibitors...
179 - Annual Dose of Sweetness: 2024 Updates from the American Diabetes Association Guidelines
In this recurring episode, we discuss the important updates from the 2024 American Diabetes Association Guidelines!
Key Concepts
Reference...
178 - Law & Order: Pharmacy Edition. A Concise Review of High-Yield Pharmacy Law Topics for the MPJE
In this episode, we speak with Janeen Winnike, the Associate Dean for Student Affairs at Rosalind Franklin and a co-course director for the Pharmacy L...
177 - The Antidote Arsenal: Exploring the Emergency Toolbox for Anticoagulant Reversals
In this episode, we review evidence-based guidelines for the emergency reversal of warfarin, dabigatran, and the oral Xa inhibitors (apixaban, edoxaba...
176 - Hormonal Harmony: A Pharmacist’s Guide to Hormonal Contraceptives (Part 2)
In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contraceptives...
175 - Hormonal Harmony: A Pharmacist’s Guide to Hormonal Contraceptives (Part 1)
In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contraceptives...
174 - Finding Your Mount Rushmore: The Journey of an Industry Pharmacist
In this episode, we interview Scott Glosner, PharmD, MPH, BCPS about his extensive experience working at Pfizer in medical outcomes and as a field med...
173 - Balancing Access and Safety: The FDA's Prescription Drug Risk Mitigation Strategy (REMS)
In this episode, we will discuss the definition of REMS (Risk Evaluation and Mitigation Strategies), why they exist, the role of FDA in administering...
172 - Battle of the Clot Busters: Alteplase vs. Tenecteplase for Acute Ischemic Stroke
In this episode, we review the role and indications of thrombolytics in acute ischemic stroke. The efficacy, safety, administration considerations, an...
171 - Two Vax’s and a MAB: What’s New in RSV Prevention
In this episode, we briefly review RSV (respiratory syncytial virus) infections and focus on new data supporting the use of two different RSV vaccines...
170 - Hope and Healing: Overcoming Opioid Use Disorder Through Evidence-Based Therapies
In this episode, together with our faculty colleague, Dr. Roberta Dume, PharmD, BCPP, we discuss the pharmacologic options and evidence for the treatm...
169 - Introducing HelixTalk’s 2023 Drug Superlative Awards!
In this episode, we announce the second iteration of the HelixTalk Drug Superlative Awards -- awards given to medications on the market that are outst...
168 - Beyond the Controversy: Exploring Efficacy and Safety of Medication Abortion
There has been a lot of news about abortion (abortifacient) medications recently. Since the overturn of Roe v. Wade in 2022, individual states passed...
167 - Beyond One-Size-Fits-All: Unraveling the Genetic Tapestry of CYP2D6 Drug Metabolism
In this episode, we review the science behind genetic differences in humans in the CYP2D6 hepatic enzyme responsible for drug metabolism and how these...
166 - Thiazide Throwdown: Hydrochlorothiazide vs. Chlorthalidone - The Ultimate Showdown for Hypertension Management
In this episode, we compare hydrochlorothiazide and chlorthalidone, but specifically from a cardiovascular outcomes perspective when used in patients...
165 - QT and the Beast: Managing Medications That Prolong the QT Interval
In this episode, we discuss the concerns of QTc prolongation, which can cause a fatal arrhythmia called torsades de pointes (TdP). We cover the differ...
164 - Breaking Down the Updates: Key Changes and Implications of the 2023 American Diabetes Association Guidelines
In this episode, we will discuss the most important updates from the American Diabetes Association’s 2023 Standards of Care in Diabetes.
Key Con...
163 - The Two-Drug Tango: A Concise Guide to Tacrolimus and Mycophenolate in Organ Transplantation
In this episode, we review clinical pearls and common pitfalls of immunosuppression regimens for organ transplantation with a particular focus on tacr...
162 - A1C You Later: A Concise Review of Continuous Glucose Monitors for the Practicing Pharmacist
In this first ever CE episode, we discuss the A-Zs of continuous glucose monitors (CGMs). In specific, our learning objective for the CE are:
De...
161 - My Loss Is Your Gain! How Drug Repository Programs Are Helping Patients Afford High-cost Medications
In this episode, we interview Dr. Shannon Rotolo and Dr. Alex Berce regarding Illinois and Wisconsin drug repository programs – these are programs tha...
160 - Dextromethorphan for Depression? Analyzing Data for Auvelity® in Major Depressive Disorder
In this episode, we discuss the evidence, safety, and place in therapy of Auvelity® (dextromethorphan-bupropion), a newly approved antidepressant with...
159 - A Breath of Fresh Air: Big Changes to the 2023 GOLD Guidelines for COPD
In this episode, we highlight important changes to the 2023 GOLD Guidelines for COPD. In particular, we discuss a revision to the GOLD group classific...
158 - PADing Your Understanding of Peripheral Arterial Disease: A Brief Treatment Overview
In this episode, we will discuss all things peripheral arterial disease – definitions, staging, clinical presentation, risk factors, goals of therapy,...
157 - Everything Will Be ao-K+: Potassium Formulations and Dosing for Hypokalemia
In this episode, we review the management of a patient with hypokalemia, including both inpatient and outpatient supplementation with potassium chlori...
156 - There Is an App for That: Digital Health Advancements and More!
In this episode, we will define Digital Health, its categories and examples, describe how pharmacists are involved in DH practice, opportunities and l...
155 - Oncology 911: Tumor Lysis Syndrome as an Oncologic Emergency
In this episode, we invite Dr. Amir Ali, PharmD, BCOP to discuss with us the pathophysiology, risk factors, prevention, and treatment clinical pearls...
154 - What’s New With Paxlovid: Drug Interactions, Pharmacist Prescribing, “Paxlovid Mouth”, and a Brief Drug Review
In this episode, we review Paxlovid (nirmatrelvir/ritonavir) from the perspective of its pharmacology, efficacy, safety, pharmacists’ authority to pre...